Mufti N. Ahmad, MD | Authors


Current and Emerging Immunotherapy Strategies in Advanced Urothelial Cancers

August 20, 2018

Until recently, therapeutic options for the management of advanced urothelial cancers have been limited to traditional cytotoxic agents with modest efficacy. However, the brisk pace of recent discovery in the field of immunotherapy and molecular therapeutics has ushered in a new era for management of patients with urothelial carcinoma.